BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32529635)

  • 1. Pten deletion in Dmp1-expressing cells does not rescue the osteopenic effects of Wnt/β-catenin suppression.
    Lim KE; Hoggatt AM; Bullock WA; Horan DJ; Yokota H; Pavalko FM; Robling AG
    J Cell Physiol; 2020 Dec; 235(12):9785-9794. PubMed ID: 32529635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal β-catenin deletion from Dmp1-expressing osteocytes/osteoblasts reduces structural adaptation to loading, but not periosteal load-induced bone formation.
    Kang KS; Hong JM; Robling AG
    Bone; 2016 Jul; 88():138-145. PubMed ID: 27143110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel therapeutic approach with Caviunin-based isoflavonoid that en routes bone marrow cells to bone formation via BMP2/Wnt-β-catenin signaling.
    Kushwaha P; Khedgikar V; Gautam J; Dixit P; Chillara R; Verma A; Thakur R; Mishra DP; Singh D; Maurya R; Chattopadhyay N; Mishra PR; Trivedi R
    Cell Death Dis; 2014 Sep; 5(9):e1422. PubMed ID: 25232676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-Onset Deletion of β-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain.
    Kedlaya R; Kang KS; Hong JM; Bettagere V; Lim KE; Horan D; Divieti-Pajevic P; Robling AG
    Endocrinology; 2016 Aug; 157(8):3047-57. PubMed ID: 27253995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-cadherin adherens junctions mediate osteogenesis through PI3K signaling.
    Guntur AR; Rosen CJ; Naski MC
    Bone; 2012 Jan; 50(1):54-62. PubMed ID: 21964322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt1 signaling coordinates BMP signaling and β-catenin activity to regulate second heart field progenitor development.
    Luo W; Zhao X; Jin H; Tao L; Zhu J; Wang H; Hemmings BA; Yang Z
    Development; 2015 Feb; 142(4):732-42. PubMed ID: 25670795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
    Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
    J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-catenin signaling mediates osteoblast differentiation triggered by peptide-induced α5β1 integrin priming in mesenchymal skeletal cells.
    Saidak Z; Le Henaff C; Azzi S; Marty C; Da Nascimento S; Sonnet P; Marie PJ
    J Biol Chem; 2015 Mar; 290(11):6903-12. PubMed ID: 25631051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss.
    Hong G; He X; Shen Y; Chen X; Yang F; Yang P; Pang F; Han X; He W; Wei Q
    Stem Cell Res Ther; 2019 Aug; 10(1):277. PubMed ID: 31464653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion.
    Perry JM; He XC; Sugimura R; Grindley JC; Haug JS; Ding S; Li L
    Genes Dev; 2011 Sep; 25(18):1928-42. PubMed ID: 21890648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridging the BMP and Wnt pathways by PI3 kinase/Akt and 14-3-3zeta.
    Tian Q; He XC; Hood L; Li L
    Cell Cycle; 2005 Feb; 4(2):215-6. PubMed ID: 15655376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.
    Korkaya H; Paulson A; Charafe-Jauffret E; Ginestier C; Brown M; Dutcher J; Clouthier SG; Wicha MS
    PLoS Biol; 2009 Jun; 7(6):e1000121. PubMed ID: 19492080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
    Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
    J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model.
    Yothaisong S; Thanee M; Namwat N; Yongvanit P; Boonmars T; Puapairoj A; Loilome W
    Asian Pac J Cancer Prev; 2014; 15(23):10463-8. PubMed ID: 25556493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
    Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
    Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
    [No Abstract]   [Full Text] [Related]  

  • 18. β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation.
    Ahmad I; Morton JP; Singh LB; Radulescu SM; Ridgway RA; Patel S; Woodgett J; Winton DJ; Taketo MM; Wu XR; Leung HY; Sansom OJ
    Oncogene; 2011 Jan; 30(2):178-89. PubMed ID: 20818428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished membrane recruitment of Akt is instrumental in alcohol-associated osteopenia via the PTEN/Akt/GSK-3β/β-catenin axis.
    Chen YX; Zhu DY; Gao J; Xu ZL; Tao SC; Yin WJ; Zhang YL; Gao YS; Zhang CQ
    FEBS J; 2019 Mar; 286(6):1101-1119. PubMed ID: 30656849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.